Matsui, R., Suzuki, K., Takiguchi, T., Nishio, M., Koike, T., Hayashi, T., . . . Goto, K. (2020). 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: A multicenter, prospective, observational study. BMC Pharmacol Toxicol.
Citação norma ChicagoMatsui, Reiko, et al. "5-Hydroxytryptamine-3 Receptor Antagonist and Dexamethasone As Prophylaxis for Chemotherapy-induced Nausea and Vomiting During Moderately Emetic Chemotherapy for Solid Tumors: A Multicenter, Prospective, Observational Study." BMC Pharmacol Toxicol 2020.
ציטוט MLAMatsui, Reiko, et al. "5-Hydroxytryptamine-3 Receptor Antagonist and Dexamethasone As Prophylaxis for Chemotherapy-induced Nausea and Vomiting During Moderately Emetic Chemotherapy for Solid Tumors: A Multicenter, Prospective, Observational Study." BMC Pharmacol Toxicol 2020.